Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Optimization of the Expression of Reteplase in Escherichia coli TOP10 Using Arabinose Promoter

Fatemeh Shafiee 1 , Fatemeh Moazen 1 , Mahammad Rabbani 1 and Hamid Mir Mohammad Sadeghi 1 , *
Authors Information
1 Department of Pharmaceutical Biotechnology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2015, 10 (1); e16676
  • Published Online: February 19, 2015
  • Article Type: Research Article
  • Received: December 15, 2013
  • Revised: January 27, 2014
  • Accepted: February 23, 2014
  • DOI: 10.17795/jjnpp-16676

To Cite: Shafiee F, Moazen F, Rabbani M, Mir Mohammad Sadeghi H. Optimization of the Expression of Reteplase in Escherichia coli TOP10 Using Arabinose Promoter, Jundishapur J Nat Pharm Prod. 2015 ; 10(1):e16676. doi: 10.17795/jjnpp-16676.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003; 361(9360): 847-58[DOI][PubMed]
  • 2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993; 329(10): 673-82[DOI][PubMed]
  • 3. Baruah DB, Dash RN, Chaudhari MR, Kadam SS. Plasminogen activators: a comparison. Vascul Pharmacol. 2006; 44(1): 1-9[DOI][PubMed]
  • 4. Rijken DC. Relationships between structure and function of tissue-type plasminogen activator. Klin Wochenschr. 1988; 66 Suppl 12: 33-9[PubMed]
  • 5. Emeis JJ, van den Hoogen CM, Jense D. Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemost. 1985; 54(3): 661-4[PubMed]
  • 6. Hotchkiss A, Refino CJ, Leonard CK, O'Connor JV, Crowley C, McCabe J, et al. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator. Thromb Haemost. 1988; 60(2): 255-61[PubMed]
  • 7. Kuiper J, Van't Hof A, Otter M, Biessen EA, Rijken DC, van Berkel TJ. Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J. 1996; 313 ( Pt 3): 775-80[PubMed]
  • 8. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature. 1983; 301(5897): 214-21[PubMed]
  • 9. Weaver WD. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials. Eur Heart J. 1996; 17 Suppl F: 9-15[PubMed]
  • 10. Koda-Kimble MA. Rising women. J Am Pharm Assoc (2003). 2012; 52(5): 579-80[DOI][PubMed]
  • 11. Hilleman D, Campbell J. Efficacy, safety, and cost of thrombolytic agents for the management of dysfunctional hemodialysis catheters: a systematic review. Pharmacotherapy. 2011; 31(10): 1031-40[DOI][PubMed]
  • 12. Dormiani K, Khazaie Y, Sadeghi HM, Rabbani M, Moazen F. Cloning and expression of a human tissue plasminogen activator variant: K2S in Escherichia coli. Pak J Biol Sci. 2007; 10(6): 946-9[PubMed]
  • 13. Daniels CJ, Bole DG, Quay SC, Oxender DL. Role for membrane potential in the secretion of protein into the periplasm of Escherichia coli. Proc Natl Acad Sci U S A. 1981; 78(9): 5396-400[PubMed]
  • 14. Yu P. Enhancing survival of Escherichia coli by increasing the periplasmic expression of Cu,Zn superoxide dismutase from Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 2007; 76(4): 867-71[DOI][PubMed]
  • 15. Sambrook J, Russell DW, Russell DW. Molecular cloning: a laboratory manual (3-volume set). 2001;
  • 16. Bajorunaite E, Sereikaite J, Bumelis VA. L-arginine suppresses aggregation of recombinant growth hormones in refolding process from E. coli inclusion bodies. Protein J. 2007; 26(8): 547-55[DOI][PubMed]
  • 17. Shen T, Zhang AH, Bi L, Shi LR. [Construction, expression and identification of a single chain antibody variable (scFv) against human CD25 molecule]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007; 23(3): 264-6[PubMed]
  • 18. Gerami SM, Farajnia S, Mahboudi F, Babaei H. Optimizing refolding condition for recombinant tissue plasminogen activator. Iran J Biotechnol. 2011; 9(4): 253-9
  • 19. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993; 329(22): 1615-22[DOI][PubMed]
  • 20. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation. 1993; 87(6): 1829-39[PubMed]
  • 21. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol. 1993; 21(6): 1391-5[PubMed]
  • 22. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993; 270(10): 1211-6[PubMed]
  • 23. Jung S, Park S. Improving the expression yield of Candida antarctica lipase B in Escherichia coli by mutagenesis. Biotechnol Lett. 2008; 30(4): 717-22[DOI][PubMed]
  • 24. Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev. 1996; 60(3): 512-38[PubMed]
  • 25. Wooster MB, Luzier AB. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction. Ann Pharmacother. 1999; 33(3): 318-24[PubMed]
  • 26. Qiu J, Swartz JR, Georgiou G. Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol. 1998; 64(12): 4891-6[PubMed]
  • 27. Majidzadeh AK, Mahboudi F, Hemayatkar M, Davami F, Barkhordary F, Adeli A, et al. Human Tissue Plasminogen Activator Expression in Escherichia coli using Cytoplasmic and Periplasmic Cumulative Power. Avicenna J Med Biotechnol. 2010; 2(3): 131-6[PubMed]
  • 28. Saito Y, Ishii Y, Sasaki H, Hayashi M, Fujimura T, Imai Y, et al. Production and characterization of a novel tissue-type plasminogen activator derivative in Escherichia coli. Biotechnol Prog. 1994; 10(5): 472-9[DOI][PubMed]
  • 29. Lee HJ, Im HN. Soluble Expression and Purification of Human Tissue-type Plasminogen Activator Protease Domain. Bull Korean Chem Soc. 2010; 31(9): 2607-12[DOI]
  • 30. Choi JH, Lee SY. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol. 2004; 64(5): 625-35[DOI][PubMed]
  • 31. Mergulhao FJ, Summers DK, Monteiro GA. Recombinant protein secretion in Escherichia coli. Biotechnol Adv. 2005; 23(3): 177-202[DOI][PubMed]
  • 32. Jonasson P, Liljeqvist S, Nygren PA, Stahl S. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem. 2002; 35: 91-105[PubMed]
  • 33. Sorensen HP, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol. 2005; 115(2): 113-28[DOI][PubMed]
  • 34. Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol. 1999; 10(5): 411-21[PubMed]
  • 35. Khlebnikov A, Datsenko KA, Skaug T, Wanner BL, Keasling JD. Homogeneous expression of the P(BAD) promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology. 2001; 147: 3241-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments